EUVIMEDEUVIMED entdecken
Systematische Übersicht

Papulonodular mucinosis: a systematic review on clinicopathologic characteristics, course and treatment options

Si-Yu Luo, Qin-Xiao Wang, Kai-Yi Zhou, Li-Jia Deng, Sheng Fang iD

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2025

DOI: 10.1111/ddg.15607 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2025. Verfasst von Si-Yu Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Mucinoses, Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Papulonodular mucinosis (PNM) is a rare cutaneous mucinosis recognized as a rare variant of lupus erythematosus. There are no large‐scale cohort studies characterizing its clinicopathological features or evaluating the effectiveness of various treatment options. This study aimed to review the literature on PNMs to identify its clinical and histological features and treatment outcomes. The search includes studies from the PubMed, Embase, and Cochrane Library databases up to the March 1, 2024. A total of 37 studies, encompassing 44 patients, were included in the review. Of these, 20 were males and 24 females, with a mean age at diagnosis of 34.9 ± 1.92 years. PNM lesions are characterized by generalized papules, plaques, and nodules, and histopathologically, they show abundant mucin deposition throughout the dermis. The temporal relationship between PNM and SLE is variable. There is no evidence that SLE patients with PNM are more prone to organ involvement or increased disease activity. A combination of medical history, clinical features, and histopathological findings is essential for diagnosis; however, misdiagnosis is possible until lupus erythematosus (LE) becomes evident. Hydroxychloroquine and systemic glucocorticoids are the current mainstays of treatment for PNM, with most patients achieving partial or complete remission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MucinosesLupus Erythematosus, SystemicLupus Erythematosus, CutaneousHumansHydroxychloroquineMaleGlucocorticoidsFemaleAdult

Stichwörter der Autor:innen

Papulonodular mucinosiscutaneouslupusmucinosissystematic review

Substanzen

HydroxychloroquineGlucocorticoids

Autor:innen und Institutionen

  • Department of Dermatology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

ORCID-Profile: Sheng Fang

Zitieren

APA

Luo, S. Y., Wang, Q. X., Zhou, K. Y., Deng, L. J., & Fang, S. (2025). Papulonodular mucinosis: a systematic review on clinicopathologic characteristics, course and treatment options. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15607

Vancouver

Luo SY, Wang QX, Zhou KY, Deng LJ, Fang S. Papulonodular mucinosis: a systematic review on clinicopathologic characteristics, course and treatment options. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2025. doi:10.1111/ddg.15607

BibTeX
@article{Luo2025,
  author = {Luo, Si-Yu and Wang, Qin-Xiao and Zhou, Kai-Yi and Deng, Li-Jia and Fang, Sheng},
  title = {Papulonodular mucinosis: a systematic review on clinicopathologic characteristics, course and treatment options},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2025},
  doi = {10.1111/ddg.15607}
}
Kostenlos starten →